Profile | GDS4284 / 226726_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 280.469 | 55 |
GSM687648 | Patient 402 control | 629.006 | 67 |
GSM687653 | Patient 403 control | 293.738 | 56 |
GSM687658 | Patient 404 control | 709.722 | 69 |
GSM687663 | Patient 411 control | 547.814 | 65 |
GSM687668 | Patient 422 control | 582.326 | 66 |
GSM687673 | Patient 424 control | 1204.34 | 77 |
GSM687678 | Patient 425 control | 602.733 | 66 |
GSM687683 | Patient 427 control | 585.002 | 65 |
GSM687688 | Patient 428 control | 290.293 | 55 |
GSM687695 | Patient 441 control | 4119.6 | 92 |
GSM687699 | Patient 443 control | 624.897 | 66 |
GSM687704 | Patient 444 control | 464.924 | 63 |
GSM687707 | Patient 448 control | 416.115 | 60 |
GSM687712 | Patient 449 control | 383.233 | 59 |
GSM687719 | Patient 450 control | 1134.21 | 76 |
GSM687724 | Patient 451 control | 748.176 | 70 |
GSM687728 | Patient 452 control | 1596.13 | 81 |
GSM687646 | Patient 401 treated 24h | 167.796 | 45 |
GSM687649 | Patient 402 treated 24h | 732.538 | 69 |
GSM687665 | Patient 411 treated 24h | 662.251 | 67 |
GSM687651 | Patient 402 treated 4 weeks | 731.978 | 69 |
GSM687667 | Patient 411 treated 4 weeks | 490.612 | 63 |
GSM687670 | Patient 422 treated 24h | 715.467 | 68 |
GSM687671 | Patient 422 treated 4 weeks | 518.97 | 64 |
GSM687654 | Patient 403 treated 24h | 316.155 | 58 |
GSM687675 | Patient 424 treated 24h | 1328.14 | 78 |
GSM687685 | Patient 427 treated 24h | 709.261 | 69 |
GSM687656 | Patient 403 treated 4 weeks | 173.688 | 48 |
GSM687677 | Patient 424 treated 4 weeks | 656.678 | 67 |
GSM687687 | Patient 427 treated 4 weeks | 386.693 | 60 |
GSM687692 | Patient 428 treated 4h | 368.563 | 59 |
GSM687716 | Patient 449 treated 4h | 285.542 | 56 |
GSM687722 | Patient 450 treated 4h | 1236.48 | 77 |
GSM687680 | Patient 425 treated 24h | 397.896 | 60 |
GSM687690 | Patient 428 treated 24h | 386.305 | 60 |
GSM687700 | Patient 443 treated 24h | 1451.91 | 80 |
GSM687705 | Patient 444 treated 24h | 731.38 | 70 |
GSM687714 | Patient 449 treated 24h | 386.976 | 60 |
GSM687721 | Patient 450 treated 24h | 2471.03 | 87 |
GSM687682 | Patient 425 treated 4 weeks | 473.394 | 63 |
GSM687694 | Patient 428 treated 4 weeks | 373.593 | 59 |
GSM687702 | Patient 443 treated 4 weeks | 551.423 | 64 |
GSM687718 | Patient 449 treated 4 weeks | 243.695 | 52 |
GSM687723 | Patient 450 treated 4 weeks | 670.227 | 68 |
GSM687661 | Patient 404 treated 4h | 484.748 | 63 |
GSM687710 | Patient 448 treated 4h | 415.921 | 61 |
GSM687726 | Patient 451 treated 4h | 1058.65 | 75 |
GSM687730 | Patient 452 treated 4h | 1488.41 | 81 |
GSM687660 | Patient 404 treated 24h | 3509.66 | 91 |
GSM687697 | Patient 441 treated 24h | 2393.79 | 87 |
GSM687709 | Patient 448 treated 24h | 515.748 | 64 |
GSM687725 | Patient 451 treated 24h | 955.713 | 73 |
GSM687729 | Patient 452 treated 24h | 4543.25 | 93 |
GSM687727 | Patient 451 treated 4 weeks | 892.124 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 858.574 | 71 |